The biomedical industry continues to change its shape across the world, with the traditional giants such as California coming under threat from up-and-coming hubs in emerging economies such as Wuxi in China.

Four US mayors talk to Courtney Fingar  and Karen E Thuermer  about the importance of attracting biotech investment and what it means to their cities.

Courtney Fingar  and Karen E Thuermer  talk to regional governors and premiers from around the US and Canada about the promotion of biotechnology and find some very different approaches.

Biotechnology is riding out the recession as investment in the sector hits new highs. 

The Wallonia region of Belgium is making a big impression on the global biotech sector, with Biowin, its health cluster, leading the way.

US biotech company Geron Corporation has every reason to believe its work in stem cell and cancer research will be as groundbreaking as the Roslin Institute’s creation of cloned sheep dolly back in 1997.

With a rich history in life science research, excellent transport infrastructure and a skilled workforce, Missouri is a natural base for progressive companies involved in medical supplies and biotechnology.

Missouri has established itself as a leader in life sciences and biotechnology – boasting of the world’s leading R&D centres in this field.

An fDi Intelligence evaluation into biotech FDI between 2003 and 2011 shows that although the US is the dominant country in the sector, Asian cities lead in attractiveness for projects, competing on both quality and cost.